The INT²GRATE platform incorporates tumor-derived signature somatic profiles in selected cancers, with key clinical genetics information, to aid interpretation of germline variants and assessment of their clinical utility in cancer susceptibility genes. INT²GRATE facilitates the assembly of the integrated evidence from tumor and germline data to promote sharing data and knowledge in ClinVar and other public archives.
In selected inherited cancer syndromes, INT²GRATE requires:
• Germline variants in relevant cancer susceptibility genes
• Personal and familial genetics information
• Somatic genomic information and relevant tumor signature profiles